found that interleukin (IL)-6 can phosphorylate PD-L1 by activating Janus kinase 1 (JAK1), in turn catalyzing PD-L1 glycosylation, enhancing its stability, and promoting tumor immune escape (37). The gene discussed is CD274; the disease is neoplasm.